The Bull Case For MakeMyTrip (MMYT) Could Change Following GenAI Multilingual Trip Planning Launch

• Earlier this month, MakeMyTrip announced the launch of a GenAI-enabled Trip Planning Assistant, enhancing travel planning with voice and text support in English and Hindi, and expanding soon to additional Indian languages.
• This upgrade aims to bridge the gap for non-English speakers in India by enabling conversational travel bookings from inspiration to completion, setting MakeMyTrip apart from many global peers that stop at recommendations.
• Next, we’ll examine how this expansion of conversational, multilingual capabilities could influence MakeMyTrip’s long-term investment narrative.

Find companies with promising cash flow potential yet trading below their fair value.

MakeMyTrip Investment Narrative Recap

To be a MakeMyTrip shareholder, you need to believe India's rising digital adoption and demand for seamless, localized travel solutions can drive sustainable growth, even as competition and pricing pressure remain significant short-term risks. The recent launch of the GenAI Trip Planning Assistant could enhance customer acquisition, particularly among non-English speakers, though any near-term impact on margins or market share will depend on how quickly the upgrade converts new users in the face of aggressive competitors.

Among recent announcements, the Q1 2026 results stand out, with revenue rising to US$268.85 million but sales slightly down year-on-year, reflecting a competitive environment that keeps margins tight. The GenAI assistant builds on ongoing product innovation efforts, tying directly to catalysts like expanded online travel adoption and increased personalization, key themes supporting investment optimism, as user-friendly tools may improve both conversion and retention if adoption is strong and sustained.

However, it’s worth noting that in contrast to these opportunities, customer acquisition costs and heavy marketing spend could still limit future margin expansion, and investors should be aware that ...

Read the full narrative on MakeMyTrip (it's free!)

MakeMyTrip's narrative projects $1.8 billion revenue and $289.3 million earnings by 2028. This requires 22.2% yearly revenue growth and a $189.3 million earnings increase from $100.0 million today.

Uncover how MakeMyTrip's forecasts yield a $120.11 fair value, a 22% upside to its current price.

Exploring Other Perspectives

Three community-derived fair value estimates for MakeMyTrip range from US$36.72 to an outlier of US$180,922.76, reflecting highly divergent views among retail investors in the Simply Wall St Community. In a market where competition remains intense and margin pressure is real, consider how your view on growth aligns or contrasts with these broad perspectives.

Explore 3 other fair value estimates on MakeMyTrip - why the stock might be worth less than half the current price!

Build Your Own MakeMyTrip Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your MakeMyTrip research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free MakeMyTrip research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MakeMyTrip's overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com